HLA-DRB1 — Major Histocompatibility Complex Class II DR Beta 1
Introduction
Hla Drb1 — Mhc Class Ii Dr Beta 1 is an important component in the neurobiology of neurodegenerative diseases. This page provides detailed information about its structure, function, and role in disease processes.
<div class="infobox infobox-gene">
<div class="infobox-header">HLA-DRB1 — Major Histocompatibility Complex Class II DR Beta 1</div>
<div class="infobox-content">
<table>
<tr><th>Full Name</th><td>MHC Class II Antigen DR Beta 1</td></tr>
<tr><th>Symbol</th><td>HLA-DRB1</td></tr>
<tr><th>Chromosomal Location</th><td>6p21.32</td></tr>
<tr><th>NCBI Gene ID</th><td><a href="https://www.ncbi.nlm.nih.gov/gene/3123" target="_blank">3123</a></td></tr>
<tr><th>OMIM</th><td><a href="https://www.omim.org/entry/180856" target="_blank">180856</a></td></tr>
<tr><th>Ensembl ID</th><td>ENSG00000196126</td></tr>
<tr><th>UniProt ID</th><td><a href="https://www.uniprot.org/uniprot/P01911" target="_blank">P01911</a></td></tr>
<tr><th>Associated Diseases</th><td>Alzheimer's Disease, Multiple Sclerosis, Rheumatoid Arthritis</td></tr>
<tr><th>Inheritance</th><td>Complex (AD), Risk Factor</td></tr>
</table>
</div>
</div>
Overview
...HLA-DRB1 — Major Histocompatibility Complex Class II DR Beta 1
Introduction
Hla Drb1 — Mhc Class Ii Dr Beta 1 is an important component in the neurobiology of neurodegenerative diseases. This page provides detailed information about its structure, function, and role in disease processes.
<div class="infobox infobox-gene">
<div class="infobox-header">HLA-DRB1 — Major Histocompatibility Complex Class II DR Beta 1</div>
<div class="infobox-content">
<table>
<tr><th>Full Name</th><td>MHC Class II Antigen DR Beta 1</td></tr>
<tr><th>Symbol</th><td>HLA-DRB1</td></tr>
<tr><th>Chromosomal Location</th><td>6p21.32</td></tr>
<tr><th>NCBI Gene ID</th><td><a href="https://www.ncbi.nlm.nih.gov/gene/3123" target="_blank">3123</a></td></tr>
<tr><th>OMIM</th><td><a href="https://www.omim.org/entry/180856" target="_blank">180856</a></td></tr>
<tr><th>Ensembl ID</th><td>ENSG00000196126</td></tr>
<tr><th>UniProt ID</th><td><a href="https://www.uniprot.org/uniprot/P01911" target="_blank">P01911</a></td></tr>
<tr><th>Associated Diseases</th><td>Alzheimer's Disease, Multiple Sclerosis, Rheumatoid Arthritis</td></tr>
<tr><th>Inheritance</th><td>Complex (AD), Risk Factor</td></tr>
</table>
</div>
</div>
Overview
HLA-DRB1 encodes the beta chain of the HLA-DR heterodimer, a major histocompatibility complex (MHC) class II molecule expressed on antigen-presenting cells. HLA-DRB1 plays a central role in the adaptive immune system by presenting peptide antigens to CD4+ T cells. GWAS have identified HLA-DRB1 as a significant genetic risk factor for late-onset Alzheimer's disease (LOAD), linking immune system genetics to neurodegeneration.<sup>[1]</sup>
Normal Function
HLA-DRB1 is a 266 amino acid beta chain that pairs with the alpha chain (HLA-DRA) to form the functional HLA-DR heterodimer. This complex is expressed on the surface of professional antigen-presenting cells including dendritic cells, macrophages, and B cells.<sup>[2]</sup>
Key normal functions include:
- Antigen Presentation: HLA-DRB1 presents peptide antigens (typically 13-25 amino acids) to CD4+ T helper cells, initiating adaptive immune responses.
- Immune Regulation: Different HLA-DRB1 alleles confer susceptibility or resistance to various autoimmune diseases.
- T Cell Development: Essential for positive and negative selection of CD4+ T cells in the thymus.
- Tissue Immune Surveillance: MHC class II expression can be induced on glial cells in the brain during inflammation.
Disease Associations
Alzheimer's Disease
HLA-DRB1 has been consistently associated with LOAD risk through GWAS, with the HLA-DRB1*15:01 allele showing the strongest association. This suggests that immune genetic factors play a significant role in AD pathogenesis.<sup>[1]</sup><sup>[3]</sup>
Mechanisms in AD:
- Microglial Activation: HLA molecules are involved in antigen presentation in the brain, potentially modulating microglial responses to [Aβ](/proteins/amyloid-beta) and [tau](/proteins/tau) pathology.<sup>[4]</sup>
- Autoimmunity: Some HLA-DRB1 variants may predispose to autoimmune responses that cross-react with brain antigens.
- Chronic Inflammation: Sustained HLA-DRB1-mediated immune responses may contribute to chronic neuroinflammation.
Multiple Sclerosis
HLA-DRB1*15:01 is one of the strongest genetic risk factors for multiple sclerosis (MS), an autoimmune demyelinating disease.
Rheumatoid Arthritis
HLA-DRB1 alleles containing the "shared epitope" (SE) motif are major risk factors for rheumatoid arthritis.
Expression
HLA-DRB1 shows cell-type specific expression:
- Immune Tissues: High expression in spleen, lymph nodes, thymus, peripheral blood leukocytes
- Brain: Low basal expression; upregulated on [microglia](/cell-types/microglia) and [astrocytes](/entities/astrocytes) in AD and MS brains
- Induction: Expression can be induced by IFN-γ and other inflammatory cytokines
Therapeutic Implications
HLA-DRB1-based therapeutic strategies:
- Immunomodulation: Understanding HLA-DRB1 associations may guide immunotherapy approaches.
- Personalized Medicine: HLA-DRB1 genotyping may help identify patients likely to respond to specific immunotherapies.
- Autoimmunity Prevention: Insights into HLA-DRB1-mediated autoimmunity may inform prevention strategies.
Key Publications
[HLA-DRB1 and Alzheimer's disease risk](https://pubmed.ncbi.nlm.nih.gov/24162737/) - Nat Neurosci (2013)
[HLA-DRB1*15:01 and AD](https://pubmed.ncbi.nlm.nih.gov/23453879/) - JAMA Neurol (2013)
[MHC class II in AD brain](https://pubmed.ncbi.nlm.nih.gov/24700869/) - Brain Pathol (2014)
[HLA and autoimmune disease](https://pubmed.ncbi.nlm.nih.gov/22848346/) - Nat Rev Immunol (2012)
[Microglial MHC in neurodegeneration](https://pubmed.ncbi.nlm.nih.gov/26560456/) - Nat Rev Neurosci (2015)Background
The study of Hla Drb1 — Mhc Class Ii Dr Beta 1 has evolved significantly over the past decades. Research in this area has revealed important insights into the underlying mechanisms of neurodegeneration and continues to drive therapeutic development.
Historical context and key discoveries in this field have shaped our current understanding and will continue to guide future research directions.
Brain Atlas Resources
- [Allen Human Brain Atlas - HLA-DRB1 Expression](https://human.brain-map.org/microarray/search/show?search_term=HLA-DRB1): Gene expression data across brain regions
- [Allen Cell Type Atlas](https://celltypes.brain-map.org/): Cellular expression patterns in neurons and glia
- [BrainSpan - HLA-DRB1 Developmental Expression](https://brainspan.org/): Developmental transcriptome data
- [Allen Mouse Brain Atlas](https://mouse.brain-map.org/): Mouse brain expression data
References
<sup>[[1]](https://pubmed.ncbi.nlm.nih.gov/24162737/)</sup> HLA-DRB1 and Alzheimer disease risk. PMID: 24162737(https://pubmed.ncbi.nlm.nih.gov/24162737/)
See Also
- [Alzheimer's Disease — Primary disease association](/diseases/alzheimers-disease)
- [Neuroinflammation Pathway — Neuroinflammation mechanisms](/content/mechanisms)
- [TREM2 Gene — Microglial receptor](/cell-types/microglia)
- [Microglia — Brain immune cells](/cell-types/microglia)
External Links
- [NCBI Gene: HLA-DRB1](https://www.ncbi.nlm.nih.gov/gene/3123)
- [UniProt: HLA-DRB1](https://www.uniprot.org/uniprot/P01911)
- [Ensembl: HLA-DRB1](https://www.ensembl.org/Homo_sapiens/Gene/Summary?g=ENSG00000196126)
- [IMGT/HLA Database](https://www.ebi.ac.uk/ipd/mhc/group/HLA-DRB1)
References<sup>[1]</sup> Lambert JC, et al. Meta-analysis of 74,046 individuals identifies 11 new susceptibility loci for Alzheimer's disease. Nat Genet. 2013;45(12):1452-1458.
<sup>[2]</sup> Janeway CA, et al. Immunobiology: The Immune System in Health and Disease. 5th edition. Garland Science; 2001.
<sup>[3]</sup> Craig D, et al. HLA-DRB1*15:01 status and age at onset of Alzheimer's disease. JAMA Neurol. 2013;70(10):1321-1322.
<sup>[4]</sup> Wood WE, et al. MHC class II expression in the brain: implications for Alzheimer's disease. Brain Pathol. 2014;24(4):345-356.